netFormulary NHS
Pan Mersey
Area Prescribing Committee
 Formulary Chapter 12: Ear, nose and oropharynx - Full Section

Coronavirus guidance

Guidance to support primary care prescribers and pharmacists is available from the MLCSU Coronavirus guidance resource page. Links are provided to national resources and regional documents produced by MLCSU, RDTC, and SPS for use by Pan Mersey APC, LSCMMG, and GMMMG.

The list of resources will be updated as new material becomes available so please check back regularly for updates.

The Pan Mersey APC supports the use of COVID-specific guidance issued by NICE, and NHS England and NHS Improvement. During the COVID pandemic this will supersede any APC advice.

Ear, nose, and oropharynx

Review date: March 2022

Non-formulary drugs: Any drug or formulation not listed in the formulary is deemed to be non-formulary.

Off-label use: Drugs are included in the formulary for their licensed indications – where inclusion of off-label use is considered to be included in the formulary this is specifically stated in the formulary entry for the drug N.B. also see Paediatrics note below.

Paediatrics: Drugs are included in the formulary for paediatric use for their BNF for Children recommended indications (indicated by symbol View childrens BNF) which may be off-label, unless otherwise stated. All drugs are deemed to have the same RAG status as they have for adults unless stated otherwise.

NHS England Specialised Commissioning
Drugs carrying the NHS England logo are commissioned by them. Links to key documents, national programmes of care, and clinical reference groups are found below.

NHSE NHS England Specialised Commissioning: Key documents

NHSE NHS England Specialised Commissioning: National programmes of care and clinical reference groups

 Useful Links

12.01 Drugs acting on the ear
12.01.01 Otitis externa
Astringent preparations
Anti-infective preparations
Anti-inflammatory preparations
12.01.02 Otitis media
12.01.03 Removal of ear wax
12.02 Drugs acting on the nose
12.02.01 Drugs used in nasal allergy
12.02.02 Topical nasal decongestants
12.02.03 Nasal preparations for infection
12.02.04 Monoclonal antibodies
12.03 Drugs acting on the oropharynx
12.03.01 Drugs for oral ulceration and inflammation
12.03.02 Oropharyngeal anti-infective drugs
12.03.03 Lozenges and sprays
12.03.04 Mouthwashes, gargles, and dentifrices
12.03.05 Treatment of dry mouth
Local Treatment
Systemic treatment